2 citations
,
October 2020 in “Annals of Oncology” Androgen deprivation therapy might help prevent severe COVID-19, but more research is needed.
2 citations
,
September 1992 in “Steroids” New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.
1 citations
,
July 2025 in “Frontiers in Pharmacology” FMH foods may help manage post-acute COVID-19 symptoms safely and easily.
1 citations
,
January 2023 in “bioRxiv (Cold Spring Harbor Laboratory)” Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.
1 citations
,
November 2022 in “F1000Research” The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.
1 citations
,
March 2022 in “Irish Journal of Medical Science” Men with androgenetic alopecia and hypertension may experience more severe COVID-19.
1 citations
,
March 2022 in “F1000Research” Training programs are needed to improve home COVID-19 management practices.
1 citations
,
March 2021 in “Skin” Public interest in hair loss increased during the COVID-19 pandemic.
1 citations
,
June 2019 in “Current developments in nutrition” A patient with Ehlers-Danlos Syndrome improved after treatment for fat malabsorption and essential fatty acid deficiency.
1 citations
,
June 2019 in “Current developments in nutrition” A combination of arginine silicate complex and magnesium biotinate improves hair and nail growth in rats.
1 citations
,
June 2019 in “Current Developments in Nutrition” S-equol supplements significantly reduced menopausal symptoms in most women.
May 2026 in “International Journal for Educational Integrity” Contract cheating website traffic in Spain surged during COVID-19 but declined with the rise of AI tools.
January 2026 in “Dermatologica Sinica” Both oral and topical minoxidil effectively regrow hair in men with similar results.
December 2025 in “Brazilian Journal of Chemical Engineering” December 2025 in “Actas Dermo-Sifiliográficas” September 2025 in “International Journal of Emergency Medicine” More skin issues appeared in the emergency department during COVID-19, highlighting the need for better dermatology training and resources.
September 2025 in “Journal of Medical Internet Research” Expanding telemedicine in Japan reduced healthcare costs without harming health outcomes.
September 2025 in “International Journal For Multidisciplinary Research” Androgenetic alopecia is linked to a higher risk of metabolic syndrome.
January 2025 in “International Journal of Trichology” Severe hair loss may increase the risk of dying from COVID-19.
January 2025 in “Lume (Universidade Federal do Rio Grande do Sul)” Hair loss was the most common skin issue among healthcare workers with COVID-19.
May 2024 in “International journal of medicine and psychology.” Transcranial electrical stimulation may help reduce certain immune markers in COVID-19 patients.
Stem cell therapies, especially adipose-derived ones, show promise for treating severe COVID-19 and related conditions.
February 2024 in “PubMed” More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.
January 2024 in “International Journal of Biology Sciences” Targeted interventions based on gender, education, and age can improve COVID-19 healthcare responses.
November 2023 in “Dermatology Research and Reports” A stable ivermectin cream may effectively treat rosacea without long-term antibiotics.
September 2023 in “JP Journal of Biostatistics” The random forest model effectively helps diagnose COVID-19 using key factors like age and symptoms.
May 2023 in “Dermatology Reports” The study found that skin conditions in COVID-19 patients can signal serious internal organ damage and may be life-threatening.
January 2023 in “Open Journal of Endocrine and Metabolic Diseases” Hyperandrogenism is a common hormonal disorder in women, often linked to PCOS.
December 2022 in “Urology Herald” Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.